Aglatimagene besadenovec is under investigation in clinical trial NCT00638612 (AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.